A Randomised, Placebo-controlled, Double-blind (Sponsor Open), Segmental LPS Challenge Study to Investigate the Pharmacodynamics of GSK2798745 in Healthy Participants
Phase of Trial: Phase I
Latest Information Update: 25 Jan 2019
At a glance
- Drugs GSK 2798745 (Primary) ; Lipopolysaccharide
- Indications Cough; Heart failure
- Focus Pharmacodynamics; Proof of concept
- Sponsors GlaxoSmithKline
- 16 Jan 2019 Status changed from recruiting to discontinued.
- 05 Jul 2018 Planned primary completion date changed from 25 Sep 2018 to 3 Feb 2019.
- 05 Jul 2018 Status changed from not yet recruiting to recruiting.